Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Schizophrenia Spectrum & Other Psychotic Disorders”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00287820
What this trial is testing

Comparative Effects of Chronic Treatment With Olanzapine and Risperidone on Glucose and Lipid Metabolism

Who this might be right for
SchizophreniaDiabetesMetabolic Syndrome+1 more
Nathan Kline Institute for Psychiatric Research 46
Not applicableStudy completedNCT04240496
What this trial is testing

Clinical and Genetic Influencing Factors on Clozapine Pharmacokinetics

Who this might be right for
CYP1A2 PolymorphismCYP2C19 PolymorphismClozapine+1 more
University of Monastir 51
Not applicableStudy completedNCT03131505
What this trial is testing

INCLUDE: Using Lived Experience to Improve Mental Health Diagnosis v1

Who this might be right for
Mental Health Issue (E.G., Depression, Psychosis, Personality Disorder, Substance Abuse)SchizophreniaGeneralised Anxiety Disorder+1 more
Norfolk and Suffolk NHS Foundation Trust 59
Not applicableStudy completedNCT01878513
What this trial is testing

Prospective Cytochrome P450 Genotyping and Clinical Outcomes in Patients With Psychosis

Who this might be right for
SchizophreniaSchizoaffective DisorderPsychotic Disorder Not Otherwise Specified+1 more
Northwell Health 88
Not applicableStudy completedNCT03872310
What this trial is testing

Cognitive Enhancement on Working Memory in Patients With Schizophrenia

Who this might be right for
Memory DeficitsSchizophreniaNeurostimulator; Complications
Taipei Medical University Shuang Ho Hospital 28
Not applicableStudy completedNCT01269710
What this trial is testing

Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) Study

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder+8 more
University of North Carolina, Chapel Hill 4
Not applicableStudy completedNCT00707382
What this trial is testing

Effect of Genotyping for CYP450 Polymorphisms Versus Intense Clinical Monitoring on Antipsychotic Drug Treatment

Who this might be right for
Schizophrenia
Gesche Jurgens 311
Not applicableUnknownNCT02127879
What this trial is testing

Intensive Transcranial Magnetic Stimulation for Negative Symptoms in Schizophrenia

Who this might be right for
Schizophrenia
Brno University Hospital 40
Large-scale testing (Phase 3)Study completedNCT00034762
What this trial is testing

Efficacy and Safety of Risperidone Compared With Placebo in the Treatment of Psychotic Symptoms in Patients With Alzheimer's Disease

Who this might be right for
DementiaAlzheimer DiseaseMental Disorders
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 473
Early research (Phase 1)Looking for participantsNCT05025605
What this trial is testing

Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder

Who this might be right for
SchizophreniaSchizo-Affective DisorderSchizophreniform; Schizophrenic+2 more
BioXcel Therapeutics Inc 140
Not applicableStudy completedNCT05257720
What this trial is testing

Evaluation of the Role of Neurodegeneration in Schizophrenia

Who this might be right for
Schizophrenia
Istanbul Saglik Bilimleri University 178
Not applicableUnknownNCT05597579
What this trial is testing

Cognitive Impairments in Psychotic Disorders

Who this might be right for
Psychotic DisordersCognitive Impairment
Sheba Medical Center 200
Post-approval studies (Phase 4)Study completedNCT01795183
What this trial is testing

Effectiveness and Safety of Amisulpride in Chinese Patients With Schizophrenia

Who this might be right for
Schizophrenia
Sanofi 316
Post-approval studies (Phase 4)WithdrawnNCT05974527
What this trial is testing

Pilot Study 1: Efficacy and Safety of Sublingual Dexmedetomidine (BXCL501) for the Treatment of Agitation in the Emergency Department

Who this might be right for
AgitationSchizophreniaSchizoaffective Disorder+2 more
Brigham and Women's Hospital
Not applicableUnknownNCT03476473
What this trial is testing

Early Detection of Respiratory Disorders in Psychosis

Who this might be right for
SchizophreniaPsychosisChronic Respiratory Disease
Fundación Marques de Valdecilla 200
Not applicableNot Yet RecruitingNCT07446569
What this trial is testing

Perception and Integration of Sensory Information in the Early Stages of Psychosis

Who this might be right for
Early PsychosisSchizophrenia Prodromal
Centre Psychothérapique de Nancy 294
Testing effectiveness (Phase 2)Study completedNCT00514449
What this trial is testing

Systematic Evaluation of Antiviral Medication in Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
Konasale Prasad 31
Large-scale testing (Phase 3)Study completedNCT00309699
What this trial is testing

Evaluate the Efficacy and Safety of Flexible Doses of Extended-release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo in Patients With Bipolar I Disorder

Who this might be right for
Bipolar DisorderMood Disorders
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 493
Large-scale testing (Phase 3)Study completedNCT00338832
What this trial is testing

Effectiveness of a Lifestyle Intervention for Increasing Physical Activity in Adults With Schizophrenia

Who this might be right for
Schizophrenia
Veterans Medical Research Foundation 86
Large-scale testing (Phase 3)Study completedNCT02002832
What this trial is testing

A Clinical Trial of Lurasidone in Treatment of Schizophrenia

Who this might be right for
Schizophrenia
Marubeni Pharmaceuticals (Suzhou) Co., Ltd. 388
Next Page